SP Asset Management LLC Reduces Stock Position in Humana Inc. (NYSE:HUM)

SP Asset Management LLC lowered its position in shares of Humana Inc. (NYSE:HUM) by 3.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,127 shares of the insurance provider’s stock after selling 46 shares during the period. SP Asset Management LLC’s holdings in Humana were worth $286,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Creative Financial Designs Inc. ADV increased its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the period. Ashton Thomas Securities LLC purchased a new position in Humana during the 3rd quarter valued at $31,000. FPC Investment Advisory Inc. bought a new stake in Humana during the 4th quarter valued at approximately $27,000. Centricity Wealth Management LLC bought a new stake in Humana during the 4th quarter valued at approximately $30,000. Finally, Atwood & Palmer Inc. boosted its position in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 60 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

HUM opened at $262.10 on Thursday. The company’s 50-day simple moving average is $271.53 and its two-hundred day simple moving average is $284.92. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market capitalization of $31.62 billion, a P/E ratio of 26.34, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.35%. Humana’s dividend payout ratio (DPR) is 35.58%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HUM. Barclays lifted their price objective on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Truist Financial raised their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Finally, StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday. Twenty analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.32% of the stock is owned by company insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.